Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 99.2114.8319.94309.00-25.23

What is the latest Core EBITDA Growth ratio of SOTAC PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SOTAC PHARMACEUTICALS is 99.21 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202599.21
Mar202414.83
Mar202319.94
Mar2022309.00
Mar2021-25.23

How is Core EBITDA Growth of SOTAC PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 99.21
568.98
Mar2024 14.83
-25.63
Mar2023 19.94
-93.55
Mar2022 309
Positive
Mar2021 -25.23 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹111.0 Cr -14.5% -23% -26.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,497.0 Cr -3.5% -6.4% -2.6% Stock Analytics
DIVIS LABORATORIES ₹165,492.0 Cr -5.8% -1.6% 10.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,013.0 Cr 1.4% 7% 23.7% Stock Analytics
CIPLA ₹112,922.0 Cr -4.7% -6.8% -0.3% Stock Analytics
DR REDDYS LABORATORIES ₹98,115.0 Cr -2.8% -8.1% -11.1% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-14.5%

-23%

-26.1%

SENSEX

-0.7%

-1.9%

8%


You may also like the below Video Courses